(Q34196642)

31 July 2017

1 reference

title

Oseltamivir: a review of its use in influenza (English)

1 reference

31 July 2017

1 reference

ChEBI release 2020-05-28

K McClellan

1

1 reference

PubMed ID

11270942

31 July 2017

C M Perry

series ordinal

2

1 reference

31 July 2017

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

61

1 reference

31 July 2017

263-283

1 reference

31 July 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200161020-00011

31 July 2017

0 references

cites work

Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).

1 reference

12 December 2020

Influenza--a new problem?

1 reference

12 December 2020

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

1 reference

12 December 2020

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

1 reference

12 December 2020

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

12 December 2020

Zanamivir: a review of its use in influenza

1 reference

12 December 2020

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

12 December 2020

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

1 reference

12 December 2020

Oral oseltamivir treatment of influenza in children.

1 reference

12 December 2020

Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization

1 reference

12 December 2020

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104.

1 reference

12 December 2020

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

1 reference

12 December 2020

Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en

1 reference

12 December 2020

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

12 December 2020

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

1 reference

12 December 2020

Oral oseltamivir in human experimental influenza B infection.

1 reference

12 December 2020

Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice

1 reference

12 December 2020

Children with influenza A infection: treatment with rimantadine.

1 reference

12 December 2020

Approaches and strategies for the treatment of influenza virus infections

1 reference

12 December 2020

The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers.

1 reference

12 December 2020

Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection

1 reference

12 December 2020

Influenza virus neuraminidase inhibitors

1 reference

12 December 2020

1 reference

12 December 2020

Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population

1 reference

12 December 2020

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en

1 reference

12 December 2020

Influence of treatment schedule and viral challenge dose on the in vivo influenza virus-inhibitory effects of the orally administered neuraminidase inhibitor GS 4104

1 reference

12 December 2020

Antiviral agents for treating influenza.

1 reference

12 December 2020

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial

1 reference

12 December 2020

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

1 reference

12 December 2020

Development of antivirals against influenza

1 reference

12 December 2020

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

1 reference

12 December 2020

Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers

1 reference

12 December 2020

1 reference

12 December 2020

Influenza virus resistance to neuraminidase inhibitors

1 reference

12 December 2020

New approaches to influenza chemotherapy. Neuraminidase inhibitors

1 reference

12 December 2020

10.2165/00003495-200161020-00011

Identifiers

DOI

1 reference

PubMed ID

11270942

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11270942